borderline significancep = 0.0596
12 and its extension study 13 only showed a statistically borderline significance ( p = 0.0596) for a reduced hazard ratio (HR) for the time to the first relapse and demonstrated nonsignificant improvements in a number of secondary end points in patients treated with TCZ.